TRALYNXA Trademark

Trademark Overview


On Friday, May 7, 2021, a trademark application was filed for TRALYNXA with the United States Patent and Trademark Office. The USPTO has given the TRALYNXA trademark a serial number of 79314251. The federal status of this trademark filing is REGISTERED as of Tuesday, June 13, 2023. This trademark is owned by NOVARTIS AG. The TRALYNXA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
tralynxa

General Information


Serial Number79314251
Word MarkTRALYNXA
Filing DateFriday, May 7, 2021
Status700 - REGISTERED
Status DateTuesday, June 13, 2023
Registration Number7077397
Registration DateTuesday, June 13, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, June 13, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 13, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 19, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 19, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, April 12, 2023NOTIFICATION PROCESSED BY IB
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 8, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 1, 2023CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Wednesday, February 22, 2023ATTORNEY REVIEW COMPLETED
Monday, May 2, 2022FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Monday, February 14, 2022REG. CANCELLED - RESTORED TO PENDENCY
Tuesday, February 8, 2022ASSIGNED TO PETITION STAFF
Monday, February 7, 2022REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Thursday, February 3, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 4, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 23, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 14, 2021ASSIGNED TO EXAMINER
Monday, August 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 16, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 13, 2021APPLICATION FILING RECEIPT MAILED
Thursday, July 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 6, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, June 25, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB